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Primary infection and pathogenesis of equine herpesvirus type 1 (EHV-1) require an
intricate interaction of virus with the mucosal epithelium, mononuclear cells and the
vascular endothelium. Studies on EHV-1 have been facilitated by the development of
different in vitro models that recapitulate the in vivo tissue complexity. The available
in vitro assays can be categorized into (i) models mimicking the epithelium-peripheral
blood mononuclear cell (PBMC) interaction, which include ex vivo mucosal (nasal
and vaginal) explants and equine respiratory epithelial cells (EREC) cultures; and (ii)
PBMC-endothelium mimicking models, including flow chamber and contact assays.
These in vitro models have proven their worth in attempts to recapitulate the in vivo
architecture and complexity, produce data relevant to natural host infection, and reduce
animal use due to in vivo experiments. Although horse models are still needed for certain
experiments, e.g., EHV-1 myeloencephalopathy or vaccination studies, available in vitro
models can be used to obtain highly valuable data on virus-host tissue interactions.
Microfluidic based 3D culture system (e.g., horse-on-a-chip) could be a potential
upgraded version of these in vitro models for future research.
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INTRODUCTION
Alphaherpesviruses are a heterogeneous group of morphologically similar DNA viruses that
includes important pathogen of humans and animals. Equine herpesviruses infect mainly members
of family Equidae, but also members of other taxa, and cause substantial economic losses (1, 2).
Equine herpesviruses 1 and 4 (EHV-1 and EHV-4) are endemic in domestic horse populations
worldwide and cause respiratory conditions. EHV-1 is the prime cause of abortion, neonatal
mortality and neurological disorders (myeloencephalopathy) after a transition stage of cell-
associated viremia. EHV-1 infection of peripheral blood mononuclear cells (PBMC) plays an
essential role in transmitting the virus from the primary site of infection (respiratory tract) or
reactivation to the vasculature of target organs (3, 4).
EHV-1 pathogenesis can be divided into three main levels of infection. First, in the respiratory
epithelium, the infection starts with uptake of infectious particles and primary replication in
respiratory epithelia. Second, in mononuclear cells and dendritic cells (DC), virus is captured
from the primary site of replication (respiratory epithelia), and infected cells rapidly migrate
to lymphoid tissues associated with the upper respiratory tract and infect other mononuclear
cells that enter the blood stream (cell-associated viremia). Finally, the virus is transferred from
blood mononuclear cells to the vasculature of different tissues, where viruses can attach to, enter
and replicate in endothelial cells (EC). Disease outcomes are reflecting the pathogenetic changes
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including vasculitis, thrombosis, edema and vascular necrosis (4–
10). The process of virus spread between the three compartments
(epithelium, blood, and endothelium) is dynamic and involves
multiple steps and it is critical that the orchestration of these steps
be precisely regulated to ensure efficient virus transfer. However,
the exact mechanism at each level is still unknown and needs
further investigation.
Of course, horses are the gold standard for studying EHV-1
pathogenesis; however, this model is ethically questionable and
requires large animal biosafety facilities and trained personnel.
Absence of other suitable animal models resulted in the
development of in vitro systems to study EHV-1 pathogenesis.
The currently available in vitro models can be divided into two
main categories. (i) Epithelium-PBMCmimicking models, which
include ex vivo nasal explants and equine respiratory epithelial
cells (EREC) culture; (ii) PBMC-EC mimicking models, which
include flow chamber assay and contact assay. These models are
widely used to recapitulate in vivo architecture and investigate the
host-pathogen interaction.
EX VIVO NASAL EXPLANTS
Nasal explants provide an attractive and alternative means
to mimic the in vivo situation as a complex 3-dimentional
tissue network that keeps intact the cell-to-cell contacts present
in vivo. This model is readily accessible and is a powerful
tool to overcome problems when using infection experiments
in the natural host, including, but not restricted to, better
standardization and the possibility to performmultiple replicates
that are impossible in the horse infection model (11). Nasal
explant cultures have been successfully used to study the
pathogenesis, replication and invasion of EHV-1, EHV-3 and
EHV-4, the initial response and migration of mononuclear cells
during EHV-1 infection, basement membrane damage during
infection, and EHV-induced cytokine responses (7, 12–16).
Confocal microscopy studies showed that EHV-1 crosses the
basement membrane barrier through infected mononuclear cells,
which allows the virus to subsequently progress to draining
lymph nodes or blood vessels in lamina propria and results
in cell-associated viremia (7, 14). Migration of mononuclear
cells in response to virus infection or navigation of infected
cells to blood vessels or lymph nodes is determined by
complex network of cellular signals and the actions of cytokines
and chemokines.
Vaginal mucosal explants are a variant version of mucosal
explant cultures that were used to study EHV-1 and EHV-3 entry,
replication kinetics, virus spread and invasion characteristics.
Although both viruses can replicate efficiently, EHV-3 showed
privileged replication in the vaginal compared to nasal mucosa
due to natural virus tissue tropism (17).
EREC CULTURE
Polarized epithelial cells differentially distribute proteins and
lipids in the plasma membrane creating two distinct surfaces:
the apical surface, which faces the external environment, and
the basolateral side, which contacts the underlying cells and
systemic vasculature (18). Most studies on virus entry have been
conducted with non-polarized cells do not properly reflect in
vivo conditions. Epithelial cells grown on porous supports show
evidence of increased differentiation in comparison with cells
grown on conventional solid surfaces, which formed the base
for EREC in vitro culture model (19, 20) and was recently
adopted to study EHV-1 pathogenesis (Figure 1A) (21–23).
EREC were used to study replication kinetics and cytokine
response after infection with wild-type or mutant EHV-1 strains.
Further, an EREC-PBMC virus transfer system was developed
and has provided evidence for direct viral transfer from the
epithelium to PBMC. Viral transfer through direct cell-to-cell
contact resulted in pro-inflammatory, chemokine and antiviral
responses that were strikingly different if each cell type was
infected independently (22). In addition, the EREC system
was successfully employed to shed light on chemotaxis of
monocytes and neutrophils in response to EHV-1 infection
of respiratory epithelial cells (8). This unique primary equine
epithelial cell system closely mimics in vivo conditions of primary
infection. Further, most of the data related to EHV-1 obtained
from this in vitro system mimics in vivo data (24–26). In
conclusion, the ex vivo models confirmed the importance of
studying the cells representing different compartments of the
body during infection with EHV-1 in relation to each other,
rather than individually.
CONTACT ASSAYS
To mimic the PBMC-EC interface and to investigate the
multitude of interactions between PBMC and EC with
subsequent virus transfer, an in vitro co-cultivation system
was developed (6). The system involved either “contact” or
“non-contact” setups where both PBMC and EC are sharing the
same environment in the presence or absence of neutralizing
antibodies (Figure 1B). In the contact model and under static
conditions, EHV-1-infected PBMC were co-cultured with EC
monolayers in the presence of neutralizing antibodies, and virus
transfer from PBMC to EC was reported. In the “non-contact”
model, infected PBMC were placed into a transwell insert and
were physically separated from EC monolayers by a porous
membrane that prevents the migration of PBMC but allows the
diffusion of cell-free virus (6, 9). Virus spread from infected
PBMC to the underlying EC in the “contact” mode was reported
and tracked using confocal microscopy and live cell imaging (9).
The system proved to be flexible to study other aspects during
virus spread, particularly the role of adhesion molecules in virus
transmission (27).
FLOW CHAMBER SYSTEM
To further address the more dynamic aspects of PBMC-EC
interaction, we established a flow chamber setup, where infected
PBMC are allowed to flow (0.5 mm/s) over EC monolayers
in the presence or absence of virus-neutralizing antibodies
(Figure 1C). The whole process can be tracked by confocal
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FIGURE 1 | In vitro models to study EHV-1 pathogenesis. (A) Equine respiratory epithelial cells (EREC) culture. Cells are grown at the air-fluid interface and infected
with virus at the apical side (left panel). After removal of the inoculum, the transwell insert is inverted, a tygon pipe is applied, and PBMC are added to the generated
top chamber (right panel). (B) Contact assay. Virus-infected PBMC are applied to endothelial monolayers either in a “transwell; left panel” or “contact; right panel”
setup. (C) Flow chamber system. Endothelial cells are grown to confluency in µ-slide cell flow chambers connected to a perfusion system “syringe pump” that allow
the introduction of infected PBMC. PBMC kinetics as well as PBMC-endothelial cell interactions can be visualized with inverted fully motorized fluorescence
microscope. (D) Organ-on-a-chip microdevice. The microsystem is constructed in a layered microfluidic device with two cell culture (upper and lower) microchannels
separated by a porous flexible membrane. Epithelial and endothelial cells are grown on the upper and lower microchannels, respectively. Growth medium, virus, or
virus-infected PBMC are perfused using a syringe pump. Virus infection and transfer, kinetics of perfused PBMC, and interaction between PBMC and cell monolayers
can be visualized and tracked using live cell imaging.
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live cell fluorescence imaging and automated cell tracking.
This system can be used to document the differences between
neuropathogenic and non-neuropathogenic EHV-1 strains as
well as between EHV-1 and EHV-4 (9). The role of different viral
proteins in the process of virus spread from PBMC to EC was
precisely addressed. The system also allowed to document the
kinetics of infected vs. non-infected PBMC in terms of tethering,
adhesion, and rolling. These experiments demonstrated the value
of the flow chamber system for studying the dynamic events
during EHV-1 transfer from infected PBMC to EC, the role of
adhesion molecules, and the effects of anti-inflammatory and
anti-viral treatment on virus transmission.
Another aspect of EHV-1 pathogenesis targeting the role
of EHV-1 in thrombus formation was studied using another
flow microfluidic system. With the system, it was possible to
investigate the interaction between EHV-1 infected EC cells
and platelets. The process of capturing un-activated platelets by
infected EC and initiation of platelet aggregation was tracked in
a dynamic mode (Tracy Stokol, personal communication).
CONCLUSION AND FUTURE
PERSPECTIVES
The development of in vitro models has paved the way to
fill in the gaps in our understanding of EHV-1 and EHV-4
pathogenesis. Conducting in vivo experiments on horses
is ethically questionable and associated with high costs
that are caused by the need for specialized facilities and
highly trained personnel. Furthermore, suitable replicates
of experiments present a formidable hurdle. Available in
vitro experimental models have allowed important insight
into virus pathogenesis, virus-cell interactions, the crosstalk
between cells, and the viral and cellular determinants
governing infection.
From an animal welfare perspective, the currently available
models are important steps toward reducing the suffering of
horses during animal experiments, although some experiments,
primarily those for vaccine development, will still require
horse studies. At a technological level, the systems provide
the required level of tissue complexity that is needed for a
better understanding of virus pathogenesis; however, upgrades
are still required to mimic and recapitulate the complicated in
vivo situation.
The development of the horse-on-a-chip would be the
suitable upgrade and may represent the future of pathogenesis
models. The model would depend on the fabrication of
two parallel microchannels with a thin, porous, and flexible
polydimethylsiloxane (PDMS) membrane to recreate tissue-
tissue interfaces. Epithelial cells and microvascular endothelial
cells would be grown on the upper and lower microchannels
on the collagen-coated PDMS membrane (Figure 1D). Different
models of specialized tissues (e.g., blood vessels, gut, liver, kidney,
lung, and brain) can now be commercially microfabricated.
TABLE 1 | Main differences between 3D and 2D culture systems.
Three dimensions (3D) cell culture Two dimensions (2D) cell culture
Merits Closely mimic the in vivo microenvironment; particularly, cell-cell and
cell-extracellular matrix interactions, communication, and signaling pathway
Cells are grown in monolayers, which allow them to receive equal
amount of nutrients and growth factors
Multicellular system: it provides an opportunity to co-culture multiple cell types to
mimic the in vivo conditions
Monolayers are composed mainly of living cells; since dead cells are
detached and easily removed from culture
Gene expression profiles are more comparable to in vivo environment Often proliferate at a faster rate
Cell morphology is closely similar to its natural shape More cells are likely to be in the same stage of cell cycle
Flexible: culture conditions can be modified to recapitulate a particular
microenvironment
Well-established
More stable in culture and can survive longer, which is suitable for long-term
studies
Easy to observe, measure and analyze
Cost effective; based on the assay Cheap
Bridges the gap between in vitro assays and in vivo studies
Minimize the use of animal models
Suitable for high-throughput platforms
Demerits Cells are existing in various cell cycle stages; including proliferation, apoptosis,
and necrosis
Abnormal morphology of cells (flat and stretched) compared to in vivo
Cells (especially those in the core) do not receive equal amounts of nutrients,
oxygen, or growth factors due to the lack the complex vascular systems
Cells do not mimic the physiological in vivo microenvironment or
organ-specific structural organizations
Risk of transmission of infections agents from living-derived materials used to
fabricate scaffolds
Display different gene profiles compared to in vivo environment
Reproducibility is an issue due to batch-to-batch variations of biomimetic
scaffolds
Survive for short time before trypsinization
Microscopy imaging quality is a challenge based on scaffold sizes and material
transparency
Optimization of different protocols
Expensive for large-scale studies and high throughput assays
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TABLE 2 | Features of microfluidic systems.
Merits Demerits
Mimic in vivo microenvironment, including
dynamic conditions and shear forces
Need well-experience personnel
Tailoring the needs of single-cell or
multi-cellular cultures in the same chip
Several optimizations
Reduce contamination risk Microfabrication is a challenge
High throughput experimentations
Controlled co-culture conditions via costumed
chip architectures
Direct coupling to downstream analysis
systems
Real-time
Single cell handling flexibility
Feasibility to track cell-cell interaction, cell
proliferation, progress of infection and virus
spread using live-cell imaging
Very cost effective: it utilizes reagents in
nanoscale volumes
Enable better cell growth and proliferation in 3D
culture systems
Incorporate analytical biosensors into the
culture platform
To study virus infection and transfer, infected PBMC would
be allowed to flow with the medium over the epithelial or
endothelial monolayers in the presence or absence of neutralizing
antibodies. PBMC interaction with both monolayers could then
be visualized and tracked using live cell imaging as described
above. The flow kinetics of infected PBMC as well as virus
transfer can be also studied (28–30).
Mesenchymal stem cells (MSC) are an attractive model that
have been explored recently to study the pathogenesis of EHV-
1. MSC have the potential to differentiate into any type of cells of
mesodermal origin (31). EquineMSC can be derived from variety
of sources such as amniotic fluid, umbilical cord blood, peripheral
blood, bone marrow, adipose tissue, or gingival and periodontal
ligament (32, 33). It was shown that MSC cells are permissive for
EHV-1 lytic infection and that complete virus replication cycles
can take place in these cells (34). The Self-renewable and multi-
potent capacities of MSC (35) with their potential to be used in
3D cell culture/organoid platforms make them a useful tool to
further study in vitro organogenesis and disease modeling. Given
the fact that clinical disorders associated with EHV-1 infection
are due to ischemic tissue injury (36, 37) and that MSC can
promote angiogenesis (34), MSC based-organoids may provide
an advanced in vitro tool that enables more physiologically-
relevant experiments to be performed.
Three (3D) cell culture matrices are now widely accepted
as highly complex and dynamic systems that promote many
biological relevant functions through properly regulated cell-
cell and cell-matrix interactions, and the dynamic distribution
of oxygen, nutrients and other molecules. Currently, there
are several reports that have confirmed significant differences
in the morphology, viability, response to stimuli, gene and
protein expression, proliferation, migration, and functionality
of cells between 3D and 2D cell cultures (Table 1), which
support the transition from 2D to 3D cell culture systems
(38–40). Microfluidic technology can create a controllable,
reproducible and optimizable dynamic microenvironment that
mimics the in vivo environment and provides efficient and
high throughput cellular analysis and in situ monitoring of
cellular events (Table 2). The combination of microfluidic
technology with 3D cell culture has great potential for
in vivo-like tissue-based applications. This system has been
widely used to study cell biology for biomedical applications,
genetic assays, protein studies, intracellular signaling, multidrug
resistance, drug toxicity, inflammatory responses, early-response
cytokines, activation of vascular endothelium, up-regulation
of adhesion molecules, and pathogen detection (29, 30, 38,
40, 41). A well-designed horse-on-a-chip microdevice could
combine microfluidics and biotechnology techniques, represent
alternatives to mimic the multicellular architectures, tissue-
tissue interfaces, and physicochemical microenvironments. Such
system will provide better levels of tissue and organ functionality
compared with conventional cell culture systems, and have great
potential to advance the study of disease etiology and drug
discovery and development.
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